NEW YORK (Reuters Health) – There is no need to avoid proton pump inhibitors (PPIs) in patients on the platelet inhibitors clopidogrel or ticagrelor. The increased rates of…
NEW YORK (Reuters Health) – Data from the German drug-eluting stent (DES.DE) Registry provide no evidence of the “obesity paradox” in the setting of percutaneous coronary intervention (PCI)…
NEW YORK (Reuters Health) – Adding the multitargeted tyrosine kinase inhibitor sunitinib (Sutent; Pfizer) to docetaxel did not improve clinical outcomes when used in the first-line setting in…
NEW YORK (Reuters Health) – Giving statins before a surgery lowers the risk of heart attack in statin-naïve patients, according to a new meta-analysis. The drugs also reduced…
NEW YORK (Reuters Health) – Some elderly patients with unresected non-small cell lung cancer (NSCLC) may do better with chemoradiotherapy (CRT) than with radiotherapy (RT) alone. However, low…
NEW YORK (Reuters Health) – Newer generation everolimus-eluting stents (EES) are significantly less likely to prompt very late stent thrombosis than are the first generation of drug-eluting stents…
NEW YORK (Reuters Health) – For reversal of type 1 hepatorenal syndrome, treatment with noradrenaline seems to work as well as terlipressin and is a lot less expensive,…
NEW YORK (Reuters Health) – The everolimus-eluting stent and the sirolimus-eluting stent are equally safe and efficacious in patients with coronary artery disease, the SORT OUT IV Trial…
NEW YORK (Reuters Health) – Results of a study confirm that treatment with dapagliflozin helps patients with type 2 diabetes lose weight in addition to improving their blood…
NEW YORK (Reuters Health) – For preterm neonates at risk of retinopathy, high-dose vitamin A supplementation started soon after birth produces a significant increase in retinal function, a…
